Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an investigational treatment.
Chronic Obstructive Pulmonary Disease (COPD)
Age Range:
40 to 75
Gender:
Male and Female
Location:
West Chester, Pennsylvania
About the Study
COPD flare-ups can be stressful and may make breathing even harder. Many people still experience flare-ups even while using their daily inhalers.
This research study is looking at an investigational injectable medication. The purpose is to learn whether targeting a specific type of inflammation found in some people with COPD may help reduce future flare-ups.
Participants will continue using their regular COPD inhalers throughout the study.
Qualifications
You may be able to join if you:
- Are 40 to 75 years old
- Have COPD diagnosed at least one year ago
- Had 1 COPD flare-up in the past year that required steroid treatment
- Are a current or former smoker with 10+ pack-years
- Are using dual or triple inhaler therapy (such as ICS/LABA, LABA/LAMA, or ICS/LABA/LAMA)
- Have Type 2 inflammation, shown by higher eosinophils (can be tested during screening)
FEATURED STUDIES
Asthma
Adults and adolescents 12 years of age and older living with asthma may qualify for a clinical research study evaluating
Chronic Obstructive Pulmonary Disease (COPD)
Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an
Post-Traumatic Stress Disorder (PTSD)
Adults 18 and older living with post-traumatic stress disorder (PTSD) may qualify for a clinical research study evaluating an investigational
Bronchiectasis
Individuals with bronchiectasis who experience frequent flare-ups or ongoing respiratory symptoms may qualify for a research study evaluating a home
Hypertension & Type 2 Diabetes
Researchers are studying an investigational medication to see how effective it may be in reducing risk of heart failure for
Idiopathic Hypersomnia Study Interest List
Suburban Research Associates is conducting a clinical research study for adults with Idiopathic Hypersomnia for an upcoming study on daytime